Company intelligence / Profile preview

PulseVet

Georgia, United States

Ownership: Private
Development stage: Other

Overview

PulseVet's electrohydraulic shock wave device is commercially available in global veterinary markets, with peer-reviewed evidence supporting use in equine, canine, and feline orthopedics, soft tissue healing, and respiratory (equine asthma) conditions. Studies demonstrate significant improvements in pain, function, and healing rates, with expanding indications and real-world registry data in equine asthma showing strong efficacy and no reported adverse events.[2][3][5]

Therapeutic areas: RheumatologyPulmonologyNeurologyInfectious DiseasesOtherDermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

United States Equestrian Federation (Official Shock Wave Therapy Supplier for US Equestrian Team veterinarians)[3]

Beyond the preview

Go deeper on PulseVet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PulseVet.

Explore the full profile